Latest Danaher News & Updates

See the latest news and media coverage for Danaher. We track all announcements, press releases, and industry mentions in real time, all in one place.

Danaher

Life sciences and diagnostics innovator

danaher.com

Headquarters: Washington, United States
Founded year: 1984
Company type: Public company
Number of employees: 55,000+
Industry: Advanced Medical Equipment & Technology

Last updated Today

Latest news about Danaher

In short: Danaher completed its $9.9 billion acquisition of Masimo and raised its 2026 earnings guidance following strong quarterly performance.

Company announcements

July 28 Danaher

Danaher congratulates Masimo on FDA clearance

The clearance covers the first brain-monitoring sedation score for children, aiding clinicians in decision-making.

July 21 Danaher

Danaher reports second quarter 2026 results

Net earnings rose 60% to $870 million, revenue up 5.5% to $6.3 billion, and full-year guidance raised.

June 29 Danaher

Danaher Foundation commits $1 million to Ebola outbreak relief in Central Africa

Funding will support infection prevention, hygiene, community health services, and emergency food assistance through Save the Children, IRC, and WFP.

June 22 Danaher

Danaher announces Q2 2026 earnings conference call

The webcast will take place on July 21, 2026, at 8 a.m. ET, discussing financial performance and future expectations.

Media coverage

July 30 The Markets Daily

Danaher (NYSE:DHR) Updates FY 2026 Earnings Guidance - Markets Daily

Danaher (NYSE:DHR – Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 8.450-8.600 for the period, compared...

July 29 Telecare Aware

Catching up to Masimo’s ‘unfinished’ business: Danaher completes $9.9B acquisition of Masimo. $634 million damages from Apple upheld, but Kiani lawsuits continue

The Apple Watch litigation ended with a Federal win for Masimo. It won the Federal patent infringement case in November and was awarded $634 million...

July 23 MSN

The 'standout performance' that could save Thermo Fisher, Danaher and others

Thermo Fisher stock led a medtech rebound Thursday, easing investors' fears of continued malaise for the medical research and ...

July 23 Morningstar

Danaher Up Over 6%, on Pace for Largest Percent Increase Since October 2025 — Data Talk

Up 17.97% from its 52-week closing low of $161.91 on May 15, 2026 --Traded as high as $191.72 --Up 7.03% at today's intraday high; largest...

Never miss news about Danaher

Track Danaher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.